Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Kevin K. Wu, Michael P. Lee, Erica B. Lee & Jashin J. Wu. (2020) Risk of herpes zoster with IL-17 inhibitor therapy for psoriasis and other inflammatory conditions. Journal of Dermatological Treatment 31:4, pages 359-365.
Read now
Read now
Maria Soledad Ormaechea, Muhammad Hassan, Neil Onghanseng, Jung Hyun Park, Sarakshi Mahajan, Khalid Yusuf Al-Kirwi, Gunay Uludag, Muhammad Sohail Halim, Ariel Schlaen, Yasir J Sepah, Diana V Do & Quan Dong Nguyen. (2019) Safety of systemic therapy for noninfectious uveitis. Expert Opinion on Drug Safety 18:12, pages 1219-1235.
Read now
Read now
Yi-Hsing Chen, Hellen MDS de Carvalho, Umut Kalyoncu, Lyndon John Q Llamado, Gaston Solano, Ron Pedersen, Galina Lukina, Juan J Lichauco & Radu S Vasilescu. (2018) Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice. Biologics: Targets and Therapy 12, pages 1-9.
Read now
Read now
Nawaf AlMutairi & Hesham Alaadin Abouzaid. (2018) Safety of biologic agents for psoriasis in patients with viral hepatitis. Journal of Dermatological Treatment 29:6, pages 553-556.
Read now
Read now
Arash Maleki, Halea Meese, Haitham Sahawneh & C. Stephen Foster. (2016) Progress in the understanding and utilization of biologic response modifiers in the treatment of uveitis. Expert Review of Clinical Immunology 12:7, pages 775-786.
Read now
Read now
Mauro Viganò, Giuseppe Serra, Giovanni Casella, Glenda Grossi & Pietro Lampertico. (2016) Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders. Expert Opinion on Biological Therapy 16:7, pages 917-926.
Read now
Read now
Valeria Kheir, Jean Vaudaux & Yan Guex-Crosier. (2016) Review of the latest systemic treatments for chronic non-infectious uveitis. Expert Review of Ophthalmology 11:2, pages 111-133.
Read now
Read now
Francesco Caso, Luca Cantarini, Filomena Morisco, Antonio Del Puente, Roberta Ramonda, Ugo Fiocco, Ennio Lubrano, Rosario Peluso, Paolo Caso, Mauro Galeazzi, Leonardo Punzi, Raffaele Scarpa & Luisa Costa. (2015) Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection. Expert Opinion on Biological Therapy 15:5, pages 641-650.
Read now
Read now
Cristiano Pagnini, Kristen O Arseneau & Fabio Cominelli. (2015) Safety considerations when using anti-TNFα therapy to treat Crohn’s disease. Expert Opinion on Drug Safety 14:1, pages 31-44.
Read now
Read now
Nozomi Iwanaga, Tomoki Origuchi, Kaoru Terada, Yukitaka Ueki, Yasuhiro Kamo, Noboru Kinoshita, Nobuhisa Yonemitsu, Shin-Ya Kawashiri, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura & Atsushi Kawakami. (2014) Rheumatoid arthritis complicated with severe liver injury during treatment with abatacept. Modern Rheumatology 24:5, pages 874-876.
Read now
Read now
Hong Yang & Arthur Kavanaugh. (2014) Adverse effects of golimumab in the treatment of rheumatologic diseases. Expert Opinion on Drug Safety 13:1, pages 103-112.
Read now
Read now
Articles from other publishers (60)
Yi-Jung Li, Jiun-Wen Wang, Hsin-Hsu Wu, Hsu-Han Wang, Yang-Jen Chiang, Huang-Yu Yang, Hsiang-Hao Hsu, Chih-Wei Yang & Ya-Chung Tian. (2022) Tumor necrosis factor-alpha blockade suppresses BK polyomavirus replication. Infection 51:4, pages 967-980.
Crossref
Crossref
Elena Campione, Sara Lambiase, Ruslana Gaeta Shumak, Marco Galluzzo, Caterina Lanna, Gaetana Costanza, Cristiana Borselli, Fabio Artosi, Terenzio Cosio, Lorenzo Tofani, Annunziata Dattola, Francesca Di Daniele & Luca Bianchi. (2023) A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients. Pharmaceuticals 16:4, pages 526.
Crossref
Crossref
Kevin D. Deane, Daniel Aletaha, Joan M. Bathon, Paul Emery, George E. Fragoulis, V. Michael Holers, T. W. J. Huizinga, Jason R. Kolfenbach, James R. O’Dell, Duane W. Pearson, Elizabeth Park, Josef Smolen, Yoshiya Tanaka, Peter C. Taylor, Annette van der Helm-van Mil, Ronald F. van Vollenhoven & E. William St. Clair. 2023. A Clinician's Pearls & Myths in Rheumatology. A Clinician's Pearls & Myths in Rheumatology
1
23
.
Chrong-Reen Wang & Hung-Wen Tsai. (2022) Autoimmune liver diseases in systemic rheumatic diseases. World Journal of Gastroenterology 28:23, pages 2527-2545.
Crossref
Crossref
Luigi Gargiulo, Giulia Pavia, Mario Valenti, Ana Lleo de Nalda, Chiara Perugini, Antonio Costanzo & Alessandra Narcisi. (2022) Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study. Dermatology and Therapy 12:5, pages 1263-1270.
Crossref
Crossref
Julie J. Hong, Edward K. Hadeler, Megan L. Mosca, Nicholas D. Brownstone, Tina Bhutani & Wilson J. Liao. (2022) TNF-Alpha Inhibitors and Ustekinumab for the Treatment of Psoriasis: Therapeutic Utility in the Era of IL-17 and IL-23 Inhibitors. Journal of Psoriasis and Psoriatic Arthritis 7:2, pages 79-92.
Crossref
Crossref
Karyl S. Barron, Ivona Aksentijevich, Natalie T. Deuitch, Deborah L. Stone, Patrycja Hoffmann, Ryan Videgar-Laird, Ariane Soldatos, Jenna Bergerson, Camilo Toro, Cornelia Cudrici, Michele Nehrebecky, Tina Romeo, Anne Jones, Manfred Boehm, Jennifer A. Kanakry, Dimana Dimitrova, Katherine R. Calvo, Hawwa Alao, Devika Kapuria, Gil Ben-Yakov, Dominique C. Pichard, Londa Hathaway, Alessandra Brofferio, Elisa McRae, Natalia Sampaio Moura, Oskar Schnappauf, Sofia Rosenzweig, Theo Heller, Edward W. Cowen, Daniel L. Kastner & Amanda K. Ombrello. (2022) The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort. Frontiers in Immunology 12.
Crossref
Crossref
Marouf Alhalabi, Kamal Alaa Eddin, Fadwa Ali & Ahmad Abbas. (2022) SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis. Medicine 101:4, pages e28722.
Crossref
Crossref
Wei Huang, Lingyao Du & Hong Tang. (2021) Hepatitis B virus reactivation: overview and management. Future Virology 16:12, pages 821-835.
Crossref
Crossref
Vincenzo Craviotto, Federica Furfaro, Laura Loy, Alessandra Zilli, Laurent Peyrin-Biroulet, Gionata Fiorino, Silvio Danese & Mariangela Allocca. (2021) Viral infections in inflammatory bowel disease: Tips and tricks for correct management. World Journal of Gastroenterology 27:27, pages 4276-4297.
Crossref
Crossref
Chak Sing Lau, Yi-Hsing Chen, Keith Lim, Marc de Longueville, Catherine Arendt & Kevin Winthrop. (2020) Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data. Clinical Rheumatology 40:3, pages 867-875.
Crossref
Crossref
Radoslav Marinov, Nadezhda Markova, Stefka Krumova, Kamelia Yotovska, Maya M. Zaharieva & Petia Genova-Kalou. (2020) Antiviral properties of chalcones and their synthetic derivatives: a mini review. Pharmacia 67:4, pages 325-337.
Crossref
Crossref
Matthew Ladda, Charles Lynde & Patrick Fleming. (2020) Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis. Journal of Cutaneous Medicine and Surgery 24:6, pages 625-632.
Crossref
Crossref
Ma. Junaliah Tuazon Kels, Esther NgZahrah Al Rumaih, Pratikshya Pandey, Sigrid R. RuulsHeinrich KornerTimothy P. NewsomeGeeta Chaudhri & Gunasegaran Karupiah. (2020) TNF deficiency dysregulates inflammatory cytokine production, leading to lung pathology and death during respiratory poxvirus infection. Proceedings of the National Academy of Sciences 117:27, pages 15935-15946.
Crossref
Crossref
Nora Kogan, Nélida Raimondo, Simon E. Gusis, Ariel Izcovich, Jorge A. Abarca Duran, Lilia Barahona‐Torres, Orestes Blanco, Gerardo B. Quintana, María C. Briones, Carla Castro, Evelyn G. Castro Vargas, Juan Criniti, Juan C. Diez de Medina, Manuel Franco, Minerva Gómez, Patricia Levrero, Jaime E. Martínez López & Fernando Valenzuela. (2019)
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
SOLAPSO
– Sociedad Latinoamericana de Psoriasis
(Latin American Psoriasis Society)
. International Journal of Dermatology 58:S1, pages 4-28.
Crossref
Crossref
Yun-Chi Lu, Chih-Hung Chuang, Kuo-Hsiang Chuang, I-Ju Chen, Bo-Cheng Huang, Wen-Han Lee, Hsin-Ell Wang, Jia-Je Li, Yi-An Cheng, Kai-Wen Cheng, Jaw-Yuan Wang, Yuan-Chin Hsieh, Wen-Wei Lin & Tian-Lu Cheng. (2019) Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy. PLOS Biology 17:6, pages e3000286.
Crossref
Crossref
S.A.R. Siegel, K.L. Winthrop, B.D. Ehst & A. Ortega Loayza. (2019) Ustekinumab use in patients with severe psoriasis co‐infected with hepatitis B and/or C. British Journal of Dermatology 180:5, pages 1232-1233.
Crossref
Crossref
Agazi Gebreselassie, Farshad Aduli & Charles D. Howell. (2019) Rheumatologic Diseases and the Liver. Clinics in Liver Disease 23:2, pages 247-261.
Crossref
Crossref
Jakub Wroński & Piotr Fiedor. (2019) The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought?. The Journal of Clinical Pharmacology 59:4, pages 445-462.
Crossref
Crossref
Alexandr Zinchuk, Oleksandr Herasun, Andrij Zadorozhnyi, Olga Vorozhbyt & Borys Gerasun. (2019) INFLUENCE OF AUTOLEUKOCYTE VACCINATION ON ACTIVITY LEVEL OF TUMOR NECROSIS FACTOR ALPHA IN PATIENTS WITH CHRONIC HEPATITIS B. Wiadomości Lekarskie 72:1, pages 31-34.
Crossref
Crossref
Nuno Gomes, Beatriz Leão, Cândida Abreu, Filomena Azevedo & Sofia Magina. (2019) Asymptomatic reactivation of hepatitis B virus after prolonged treatment with etanercept. Acta Dermatovenerologica Alpina Pannonica et Adriatica 28:4.
Crossref
Crossref
Shivani B. Kaushik & Mark G. Lebwohl. (2019) Psoriasis: Which therapy for which patient. Journal of the American Academy of Dermatology 80:1, pages 43-53.
Crossref
Crossref
Jean-Luc Davignon, Benjamin Rauwel, Yannick Degboé, Arnaud Constantin, Jean-Fredéric Boyer, Andrey Kruglov & Alain Cantagrel. (2018) Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Chi Chiu Mok. (2018) Hepatitis B and C infection in patients undergoing biologic and targeted therapies for rheumatic diseases. Best Practice & Research Clinical Rheumatology 32:6, pages 767-780.
Crossref
Crossref
Loris Lopetuso, Giammarco Mocci, Manuela Marzo, Francesca D’Aversa, Gian Rapaccini, Luisa Guidi, Alessandro Armuzzi, Antonio Gasbarrini & Alfredo Papa. (2018) Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver. International Journal of Molecular Sciences 19:8, pages 2199.
Crossref
Crossref
James S. Dooley & Christopher McNamara. 2018. Sherlock's Diseases of the Liver and Biliary System. Sherlock's Diseases of the Liver and Biliary System
622
651
.
Renée M. Marchioni Beery & Joshua R. Korzenik. 2018. Treatment of Inflammatory Bowel Disease with Biologics. Treatment of Inflammatory Bowel Disease with Biologics
185
211
.
Ying-Ming Chiu, Mei-Shu Lai & K. Arnold Chan. (2017) Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Nicola Imperatore, Fabiana Castiglione, Antonio Rispo, Anna Sessa, Nicola Caporaso & Filomena Morisco. (2017) Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases. Frontiers in Pharmacology 8.
Crossref
Crossref
Fabiola Atzeni, Ignazio Francesco Masala, Manuela di Franco & Piercarlo Sarzi-Puttini. (2017) Infections in rheumatoid arthritis. Current Opinion in Rheumatology 29:4, pages 323-330.
Crossref
Crossref
P. Gisondi, G. Altomare, F. Ayala, F. Bardazzi, L. Bianchi, A. Chiricozzi, A. Costanzo, A. Conti, P. Dapavo, C. De Simone, C. Foti, L. Naldi, A. Offidani, A. Parodi, S. Piaserico, F. Prignano, F. Rongioletti, L. Stingeni, M. Talamonti & G. Girolomoni. (2017) Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. Journal of the European Academy of Dermatology and Venereology 31:5, pages 774-790.
Crossref
Crossref
Eun-Jung ParkKyu-sik ChoiByung-Cheol Song. (2017) Reactivation of Hepatitis B Virus and Its Prevention in Patients with Rheumatic Diseases Receiving Immunosuppressive Therapy. Journal of Rheumatic Diseases 24:5, pages 261.
Crossref
Crossref
Melissa Padovan, Matteo Filippini, Angela Tincani, Elisabetta Lanciano, Eleonora Bruschi, Oscar Epis, Pietro Garau, Alessandro Mathieu, Eleonora Celletti, Leopoldo Giani, Paola Tomietto, Fabiola Atzeni, Piercarlo Sarzi Puttini, Francesca Zuliani, Salvatore De Vita, Francesco Trotta, Anastasio Grilli, Massimo Puoti & Marcello Govoni. (2016) Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection. Arthritis Care & Research 68:6, pages 738-743.
Crossref
Crossref
Wenshi Wang, Lei Xu, Johannes H. Brandsma, Yijin Wang, Mohamad S. Hakim, Xinying Zhou, Yuebang Yin, Gwenny M. Fuhler, Luc J. W. van der Laan, C. Janneke van der Woude, Dave Sprengers, Herold J. Metselaar, Ron Smits, Raymond A. Poot, Maikel P. Peppelenbosch & Qiuwei Pan. (2016) Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV. Scientific Reports 6:1.
Crossref
Crossref
Frederik C. J. Bester, Fredricka J. Bosch & Barend J. Jansen van Rensburg. (2016) The specialist physician’s approach to rheumatoid arthritis in South Africa. The Korean Journal of Internal Medicine 31:2, pages 219-236.
Crossref
Crossref
Gianluca Andrisani, Alessandro Armuzzi, Manuela Marzo, Carla Felice, Daniela Pugliese, Alfredo Papa & Luisa Guidi. (2016) What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:3, pages 387.
Crossref
Crossref
Claudio Bonifati, Viviana Lora, Dario Graceffa & Lorenzo Nosotti. (2016) Management of psoriasis patients with hepatitis B or hepatitis C virus infection. World Journal of Gastroenterology 22:28, pages 6444.
Crossref
Crossref
Wagdi Almishri, Tania Santodomingo-Garzon, Tyson Le, Danuta Stack, Christopher H. Mody & Mark G. Swain. (2016) TNFα Augments Cytokine-Induced NK Cell IFNγ Production through TNFR2. Journal of Innate Immunity 8:6, pages 617-629.
Crossref
Crossref
Mauro Viganò & Massimo Colombo. (2015) Extrahepatic Manifestations of Hepatitis C Virus. Gastroenterology Clinics of North America 44:4, pages 775-791.
Crossref
Crossref
Miguel Cordero-Coma & Lucia Sobrin. (2015) Anti–tumor necrosis factor-α therapy in uveitis. Survey of Ophthalmology 60:6, pages 575-589.
Crossref
Crossref
J.-J. Zhang, Y.-C. Fan, Z.-H. Zhang, J. Han, L.-Y. Wang, T. Li, F. Zhang, Y.-P. Yin, L.-H. Hu, Y. Yang, F.-K. Sun & K. Wang. (2015) Methylation of suppressor of cytokine signalling 1 gene promoter is associated with acute-on-chronic hepatitis B liver failure. Journal of Viral Hepatitis 22:3, pages 307-317.
Crossref
Crossref
Juan Felipe Betancur, Diego Fernando Jiménez, Fabio Bonilla-Abadía & Gabriel Jaime Tobón. (2015) Compromiso hepático de las enfermedades autoinmunes sistémicas. Revista Colombiana de Reumatología 22:1, pages 47-58.
Crossref
Crossref
Fang Guo, Yanxing Han, Xuesen Zhao, Jianghua Wang, Fei Liu, Chunxiao Xu, Lai Wei, Jian-Dong Jiang, Timothy M. Block, Ju-Tao Guo & Jinhong Chang. (2015) STING Agonists Induce an Innate Antiviral Immune Response against Hepatitis B Virus. Antimicrobial Agents and Chemotherapy 59:2, pages 1273-1281.
Crossref
Crossref
Tuncer Temel, D?nd? ?sk?dar Cansu, Cengiz Korkmaz, Timu?in Ka?ifo?lu & Ay?eg?l ?zakyol. (2015) The long-term effects of anti-TNF-? agents on patients with chronic viral hepatitis C and B infections. International Journal of Rheumatic Diseases 18:1, pages 40-45.
Crossref
Crossref
Peter C. Taylor. 2015. Rheumatology. Rheumatology
492
510
.
Valentina Germano, Maria Sofia Cattaruzza, John Osborn, Aurora Tarantino, Roberta Di Rosa, Simonetta Salemi & Raffaele D’Amelio. (2014) Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists. Journal of Translational Medicine 12:1.
Crossref
Crossref
C. Loras, J.P. Gisbert, M.C. Saro, M. Piqueras, C. S?nchez-Montes, J. Barrio, I. Ord?s, A. Montserrat, R. Ferreiro, Y. Zabana, M. Chaparro, F. Fern?ndez-Ba?ares & M. Esteve. (2014) Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3). Journal of Crohn's and Colitis 8:11, pages 1529-1538.
Crossref
Crossref
Uri Kopylov & Waqqas Afif. (2014) Risk of Infections with Biological Agents. Gastroenterology Clinics of North America 43:3, pages 509-524.
Crossref
Crossref
Anil Seetharam, Robert Perrillo & Robert Gish. (2014) Immunosuppression in Patients with Chronic Hepatitis B. Current Hepatology Reports 13:3, pages 235-244.
Crossref
Crossref
M.I. Biondo, V. Germano, M. Pietrosanti, M. Canzoni, M. Marignani, T. Stroffolini, S. Salemi & R. D'Amelio. (2014) Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies. European Journal of Internal Medicine 25:5, pages 482-484.
Crossref
Crossref
Jessica P. Hwang & Anna S.-F. Lok. (2013) Management of patients with hepatitis B who require immunosuppressive therapy. Nature Reviews Gastroenterology & Hepatology 11:4, pages 209-219.
Crossref
Crossref
John Koo, Ethan Levin, Argentina Leon, Jashin Wu & Alice GottliebDaniel Butler, Faranak Kamangar, Ethan Levin, John Koo & Anne Chang. 2014. Moderate to Severe Psoriasis, Fourth Edition. Moderate to Severe Psoriasis, Fourth Edition
335
348
.
Roberta Elisa Rossi. (2014) Anti-tumour necrosis factor agent and liver injury: Literature review, recommendations for management. World Journal of Gastroenterology 20:46, pages 17352.
Crossref
Crossref
Michelle C.M. Cheung & Kosh Agarwal. (2013) Liver abnormalities in the immunosuppressed. Best Practice & Research Clinical Gastroenterology 27:4, pages 597-618.
Crossref
Crossref
Shaheen H. Ensanyat, Adam J. Luber & Jacob O. Levitt. (2018) Successful Treatment of Plaque Psoriasis with Ustekinumab in a Patient with Chronic Hepatitis B and Latent Tuberculosis. Psoriasis Forum 19a:2, pages 80-83.
Crossref
Crossref
Marwan Ghabril, Herbert L. Bonkovsky, Clarissa Kum, Tim Davern, Paul H. Hayashi, David E. Kleiner, Jose Serrano, Jim Rochon, Robert J. Fontana & Maurizio Bonacini. (2013) Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases. Clinical Gastroenterology and Hepatology 11:5, pages 558-564.e3.
Crossref
Crossref
Haris Riaz, Faryal Tahir & Muhammad Bilal Munir. (2012) On the role of pentoxifylline versus other TNF alpha inhibitors in the prevention of hepatorenal syndrome. Medical Hypotheses 79:4, pages 552-553.
Crossref
Crossref
Rachel Byng-Maddick & Michael Ehrenstein. (2012) Infections in biological agents used in rheumatic disease. British Journal of Hospital Medicine 73:9, pages 517-520.
Crossref
Crossref
Sarah C Horton, Jackie L Nam & Maya H Buch. (2012) Safety of biologics in rheumatoid arthritis. International Journal of Clinical Rheumatology 7:4, pages 425-451.
Crossref
Crossref
Trinitario Pina & Ricardo Blanco. 2012. Tratamiento de la uve?tis con f?rmacos anti-TNF-alfa. Tratamiento de la uve?tis con f?rmacos anti-TNF-alfa
23
27
.